Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Department of Molecular Biology, Scripps Research Institute, La Jolla, CA 92037, USA.
This article will discuss the motivations, technologies, and future directions of computational automated docking in the context of the structure-based rational design of HIV-1 protease inhibitors. Docking simulations are widely used for screening of compound libraries to identify new drug leads, employing a simple model for rapid testing of thousands of compounds. Docking simulations are also useful for lead enhancement, using more detailed models to analyze the atomic interactions between inhibitors and target macromolecules. Major advances have been reported in the development of empirical force fields, which now allow assessment of relative binding strength and drug specificity, and extensions of automated docking techniques allow de novo drug design.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on